banner

Investors

At Acadia, we remain deeply committed to providing important new therapies to patients and delivering value for our stockholders. Our Investor Center is designed to provide you with convenient access to company information.

Recent News

04/21/21
Company to host conference call and webcast on Wednesday, May 5, 2021 , at 5:00 p.m. Eastern Time SAN DIEGO --(BUSINESS WIRE)--Apr. 21, 2021-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will report first quarter 2021 financial results on Wednesday, May 5, 2021 , after the
04/05/21
- Conference call and webcast to be held today at 8:00 a.m. Eastern Time SAN DIEGO --(BUSINESS WIRE)--Apr. 5, 2021-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Company has received a Complete Response Letter (CRL) from the U.S.
03/08/21
- Conference call and webcast to be held today at 5:00 p.m. Eastern Time SAN DIEGO --(BUSINESS WIRE)--Mar. 8, 2021-- Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the Company received a notification from the U.S. Food and Drug Administration (FDA) on March 3, 2021 , stating that,